Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer

被引:39
作者
Bermejo, JL
Eng, C
Hemminki, K
机构
[1] German Canc Res Ctr DKFZ, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Case Western Reserve Univ, Sch Med, Genom Med Inst, Cleveland Clin Lerner Coll Med,Dept Genet, Cleveland, OH 44106 USA
[3] Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43210 USA
[4] Karolinska Inst, Dept Biosci, Novum, Huddinge, Sweden
关键词
D O I
10.1053/j.gastro.2005.09.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The present study quantified the prevalence of families that fulfill the Amsterdam or Bethesda criteria for hereditary nonpolyposis colorectal cancer (HNPCC) in the whole Swedish population and investigated the extent to which tumors in the classified families are HNPCC-related. Methods: The families of the Swedish Family-Cancer Database with at least 4 generations (N = 566,877) were classified according to the Amsterdam and the Bethesda criteria. Survival methods were used to assess the risk of cancer in the classified families, the prognosis of cancer patients, and the risk of subsequent malignancies after colorectal adenomas and after colorectal/endometrial adenocarcinomas. Results: The Bethesda criteria identified 0.9% of all Swedish families and 11.2% of patients with colorectal cancer. Families that fulfilled the Bethesda criteria showed increased risks of cancer in the colorectum, endometrium, small bowel, ovary, stomach, bile ducts, renal pelvis, and ureter; members of Bethesda criteria families were at decreased risks of lung and cervical cancers. The prognosis of cancer in the ureter, renal pelvis, stomach, ovary, and colorectum, but not in the endometrium, was better in Bethesda criteria than in nonclassified families. Conclusions: Most malignancies in the classified families reflect typical features of HNPCC (association with subsequent malignancies, accelerated adenoma-carcinoma sequence, and better survival). The data presented in this study should help to define surveillance strategies for members of families that fulfill the criteria for HNPCC testing.
引用
收藏
页码:1889 / 1899
页数:11
相关论文
共 52 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]   Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[3]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[4]  
2-C
[5]   Molecular and clinical characteristics of MSH6 variants:: An analysis of 25 index carriers of a germline variant [J].
Berends, MJW ;
Wu, Y ;
Sijmons, RH ;
Mensink, RGJ ;
van der Sluis, T ;
Hordijk-Hos, JM ;
de Vries, EGE ;
Hollema, H ;
Karrenbeld, A ;
Buys, CHCM ;
van der Zee, AGJ ;
Hofstra, RMW ;
Kleibeuker, JH .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (01) :26-37
[6]   THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
FISHEL, R ;
LESCOE, MK ;
RAO, MRS ;
COPELAND, NG ;
JENKINS, NA ;
GARBER, J ;
KANE, M ;
KOLODNER, R .
CELL, 1993, 75 (05) :1027-1038
[7]   Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC [J].
Fujita, S ;
Moriya, Y ;
Sugihara, K ;
Akasu, T ;
Ushio, K .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (05) :351-355
[8]   AGA technical review on hereditary colorectal cancer and genetic testing [J].
Giardiello, FM ;
Brensinger, JD ;
Petersen, GM .
GASTROENTEROLOGY, 2001, 121 (01) :198-213
[9]  
Hemminki K, 1998, GENET EPIDEMIOL, V15, P225, DOI 10.1002/(SICI)1098-2272(1998)15:3<225::AID-GEPI2>3.3.CO
[10]  
2-S